2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on BRAF V600E Mutant mCRC: Does FDA Approved Encorafenib + Cetuximab Significantly Improve OS, ORR, PFS relative vs. SOC?

380 views
July 14, 2020
Comments 0
Login to view comments. Click here to Login